Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Colgate-Palmolive
(NYSE:CL)
Intraday
$88.33
0
[0.00%]
After-Hours
$88.33
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$88.33
0
[0.00%]
At close: Apr 22
$88.33
0
[0.00%]
PreMarket: 4:20PM EDT
Get Report
Watch
The dividend Ex-Date was 4 days ago
Q1 2024 Earnings in 3 days from now on Fri Apr 26th, before the market open
Conference call scheduled in 3 days at 8:30 AM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Colgate-Palmolive Stock (NYSE:CL)
Colgate-Palmolive Stock (NYSE: CL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, April 21, 2024
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Shanthi Rexaline
-
1 day ago
Tuesday, April 16, 2024
Citigroup Maintains Buy on Colgate-Palmolive, Raises Price Target to $100
Benzinga Newsdesk
-
6 days ago
Friday, April 12, 2024
Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $84
Benzinga Newsdesk
-
Apr 12, 2024, 10:02AM
Wednesday, April 10, 2024
9 Analysts Assess Colgate-Palmolive: What You Need To Know
Benzinga Insights
-
Apr 10, 2024, 4:00PM
Stifel Maintains Buy on Colgate-Palmolive, Raises Price Target to $94
Benzinga Newsdesk
-
Apr 10, 2024, 8:37AM
Monday, April 08, 2024
Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Raises Price Target to $96
Benzinga Newsdesk
-
Apr 8, 2024, 5:21PM
Tuesday, March 26, 2024
HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
Benzinga Newsdesk
-
Mar 26, 2024, 8:54AM
Tuesday, March 19, 2024
Here's Where To Buy Legal Weed: New Stores Launching Cannabis Sales Ahead Of 4/20, Part 1
Jelena Martinovic
-
Mar 19, 2024, 10:51AM
Friday, March 15, 2024
Colgate-Palmolive Raises Dividend By 4%, Increase To Be Effective In Q2
Nabaparna Bhattacharya
-
Mar 15, 2024, 7:50AM
Thursday, March 14, 2024
Colgate Announces Dividend Increase From $0.48 To $0.50 Per Share; Effective Q2 Of 2024
Benzinga Newsdesk
-
Mar 14, 2024, 4:37PM
Wednesday, March 13, 2024
Cannabis Co. Cresco Nearly Doubles Adjusted EBITDA YoY To $54.8M In Q4, Narrows Loss In 2023
Jelena Martinovic
-
Mar 13, 2024, 10:59AM
Monday, March 11, 2024
Top 5 Risk Off Stocks That May Plunge This Quarter
Avi Kapoor
-
Mar 11, 2024, 8:43AM
Friday, March 01, 2024
Analyst Expectations For Colgate-Palmolive's Future
Benzinga Insights
-
Mar 1, 2024, 8:00AM
Goldman Sachs Reinstates Buy on Colgate-Palmolive, Announces $93 Price Target
Benzinga Newsdesk
-
Mar 1, 2024, 7:07AM
Thursday, February 29, 2024
Boiling Water Reduces Microplastics: What Does It Mean For Coca-Cola, PepsiCo's Bottled Water Brands?
Natan Ponieman
-
Feb 29, 2024, 3:41PM
Tuesday, February 20, 2024
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
Jelena Martinovic
-
Feb 20, 2024, 9:11AM
Tuesday, January 30, 2024
Top 3 Defensive Stocks That Could Sink Your Portfolio In Q1
Avi Kapoor
-
Jan 30, 2024, 8:29AM
Monday, January 29, 2024
Colgate's Bright Smile: Analyst Envisions Upswing In 2024 Guidance With Ample Growth Opportunities
Lekha Gupta
-
Jan 29, 2024, 2:08PM
Morgan Stanley Maintains Overweight on Colgate-Palmolive, Raises Price Target to $93
Benzinga Newsdesk
-
Jan 29, 2024, 11:11AM
Colgate-Palmolive Analysts Increase Their Forecasts Following Upbeat Earnings
Avi Kapoor
-
Jan 29, 2024, 11:07AM
UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $95
Benzinga Newsdesk
-
Jan 29, 2024, 10:51AM
Ohio GOP Lawmakers Say Adult-Use Cannabis Sales Rules Could Be Ready In Spring, Promise 'Real Progress'
Jelena Martinovic
-
Jan 29, 2024, 10:04AM
Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $88
Benzinga Newsdesk
-
Jan 29, 2024, 9:41AM
Raymond James Upgrades Colgate-Palmolive to Outperform, Announces $91 Price Target
Benzinga Newsdesk
-
Jan 29, 2024, 5:30AM
Investor Sentiment Decreases Slightly Following PCE Inflation Data; S&P 500 Snaps Six-Session Win Streak
Avi Kapoor
-
Jan 29, 2024, 4:14AM
Friday, January 26, 2024
Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results
Avi Kapoor
-
Jan 26, 2024, 2:32PM
Oral Care Giant Colgate-Palmolive Plans High Brand Investment In 2024 After Beating Q4 Earnings With Solid Margins
Nabaparna Bhattacharya
-
Jan 26, 2024, 10:26AM
Nasdaq Futures Slip Ahead Of Key Inflation Data As Tech Setbacks Sap Sentiment, But Analyst Believes Recession Fears Are Fading
Shanthi Rexaline
-
Jan 26, 2024, 7:40AM
Colgate-Palmolive, On A GAAP Basis, Expects Gross Profit Margin Expansion, Increased Advertising Investment And Double-Digit EPS Growth
Benzinga Newsdesk
-
Jan 26, 2024, 6:59AM
Colgate-Palmolive Says North American Organic Sales Growth Was Led By Oral Care And Personal Care
Benzinga Newsdesk
-
Jan 26, 2024, 6:57AM
Colgate-Palmolive Sees FY24 Net Sales Growth 1-4%, Expects Organic Sales Growth Within 3-5% Range
Benzinga Newsdesk
-
Jan 26, 2024, 6:57AM
Colgate-Palmolive Q4 2023 Base Business EPS $0.87 Beats $0.85 Estimate, Sales $4.95B Beat $4.90B Estimate
Benzinga Newsdesk
-
Jan 26, 2024, 6:55AM
Intel, American Express And 3 Stocks To Watch Heading Into Friday
Avi Kapoor
-
Jan 26, 2024, 4:18AM
Investor Sentiment Increases Further Following GDP Report; S&P 500 Gains For Sixth Day
Avi Kapoor
-
Jan 26, 2024, 4:18AM
Earnings Scheduled For January 26, 2024
Benzinga Insights
-
Jan 26, 2024, 4:10AM
Thursday, January 25, 2024
Record-Breaking Cannabis Sales In Ohio Mask Stagnating Growth Rate: What's Behind The Numbers?
Jelena Martinovic
-
Jan 25, 2024, 1:48PM
Earnings Preview: Colgate-Palmolive
Benzinga Insights
-
Jan 25, 2024, 9:00AM
Monday, January 22, 2024
Tesla, Netflix, Intel Take Center Stage In Pivotal Q4 Earnings Week As S&P 500 Eyes Breaking New Highs
Shanthi Rexaline
-
Jan 22, 2024, 5:00AM
Thursday, January 18, 2024
JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $90
Benzinga Newsdesk
-
Jan 18, 2024, 2:30PM
P/E Ratio Insights for Colgate-Palmolive
Benzinga Insights
-
Jan 18, 2024, 10:30AM
Tuesday, January 16, 2024
Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $82
Benzinga Newsdesk
-
Jan 16, 2024, 12:20PM
Thursday Is Your Last Chance To Buy Colgate-Palmolive Before The Dividend Payout
Benzinga Insights
-
Jan 16, 2024, 9:45AM
Monday, December 25, 2023
Price Over Earnings Overview: Colgate-Palmolive
Benzinga Insights
-
Dec 25, 2023, 10:00AM
Friday, December 15, 2023
New York Will Get 12 New Weed Dispensaries, Ending 2023 With More Than 35 Adult-Use Stores Open
Jelena Martinovic
-
Dec 15, 2023, 12:54PM
This Colgate-Palmolive Analyst Is Turning Bullish On Heels Of CBD, Dental Pain Study
Priya Nigam
-
Dec 15, 2023, 12:13PM
Expert Ratings for Colgate-Palmolive
Benzinga Insights
-
Dec 15, 2023, 10:00AM
B of A Securities Upgrades Colgate-Palmolive to Buy, Announces $90 Price Target
Benzinga Newsdesk
-
Dec 15, 2023, 7:10AM
Wednesday, November 29, 2023
Analyst Expectations for Colgate-Palmolive's Future
Benzinga Insights
-
Nov 29, 2023, 3:00PM
JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $88
Benzinga Newsdesk
-
Nov 29, 2023, 2:19PM
Thursday, November 16, 2023
Unlocking Smiles: New Study Reveals Oral CBD As Safe & Effective Opioid Alternative For Dental Pain
Joana Scopel
-
Nov 16, 2023, 4:12PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch